allergy
Roche shares data from phase 3 trial of Xolair as allergy treatment
February 26, 2024Research and Development Allergic Disorders, Roche, Xolair, allergy, clinical trial, food allergy
Roche has announced data from stage 1 of the National Institutes of Health (NIH)-sponsored phase 3 OUtMATCH trial, which assessed …
FDA advisory committee votes in support of favourable benefit-risk profile for ARS Pharmaceuticals’ allergic reaction treatment
May 12, 2023Research and Development ARS Pharmaceuticals, Allergic Disorders, FDA, allergy
US-based biopharmaceutical company ARS Pharmaceuticals has announced that the US Food and Drug Administration (FDA)’s Pulmonary-Allergy Drug Advisory Committee (PADAC) …
Camallergy awarded £1.1m government funding for peanut allergy immunotherapy
March 9, 2021Manufacturing and Production Camallergy, UK, allergy
Camallergy, a biopharmaceutical company dedicated to providing innovative, patient-centric treatments for life-threatening food allergies, today announced it has been awarded …
European Commission approves EU’s first peanut allergy treatment
December 21, 2020Sales and Marketing Aimmune, European Commission, allergy
Aimmune Therapeutics today announced that the European Commission (EC) has approved PALFORZIA as the EU’s first-ever treatment of peanut allergy. …
The American Academy of Allergy, Asthma and Immunology calls off its 2020 Annual Meeting due to coronavirus concerns
March 10, 2020Medical Communications, Research and Development Big Pharma, allergy, america, asthma, immunology
The American Academy of Allergy, Asthma and Immunology (AAAAI) has called off its 2020 Annual Meeting that was schedule to …
FDA knocks back Glenmark’s allergic rhinitis therapy Ryaltris
June 25, 2019Manufacturing and Production, Sales and Marketing FDA, Glenmark, Ryaltris, US, allergy, pharma
Stocks in Indian pharmaceutical firm Glenmark were sent plummeting to a six-year low after it was confirmed that the FDA …
FDA approves Beximco’s generic version of MSD’s allergy drug Periactin
April 25, 2019Sales and Marketing FDA, MSD, Periactin, allergy, generics, pharma
Bangladesh-based Beximco Pharma is celebrating following the decision from the FDA to approve its generic version of MSD’s antihistamine therapy …
Aimmune’s peanut allergy therapy closes in on approval with promising Phase 3 data
March 26, 2019Manufacturing and Production, Research and Development AR101, Aimmune, allergy, pharma
Aimmune Therapeutics is gearing up for regulatory review of its investigational food allergy therapy AR101 following the release of new …
Allergy Therapeutics’ adjuvanted birch allergoid drug shocks with Phase 3 failure
March 18, 2019Research and Development, Sales and Marketing allergy, allergy therapeutics, pharma, trial failure
UK-based biotech firm Allergy Therapeutics has been left disappointed after it became evident that its adjuvanted birch allergoid product failed …
FDA accepts biologics license application for MSD’s allergy immunotherapy drug
April 13, 2016Research and Development, Sales and Marketing MSD, Merck, allergy, dust mite, house, immunotherapy, mk-8237
MSD (NYSE: MRK) has announced that the US Food and Drug Administration has accepted for review the biologics license application …
Lane Earl Cox wins allergy blood test account
April 16, 2010Medical Communications LEC, Phadia, allergy
Healthcare advertising agency Lane Earl & Cox has won the account to promote an allergy blood test product from diagnostics …
